|

Immune checkpoint inhibitor (ICI) Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • West China Hospital1
  • Stingray Therapeutics1

Indications

  • Cancer2
  • Advanced / Metastatic Solid Tumor1
  • Head and Neck Squamous Cell Carcinoma1

Other2 trials

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
Phase 1
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.